Featured Research

from universities, journals, and other organizations

Recalculating costs of combination vaccines

Date:
April 17, 2014
Source:
University of Illinois at Urbana-Champaign
Summary:
One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive option, according to a new study. The researchers encourage physicians and advisory boards to take all factors into account when determining how to administer the best combination of vaccines for the lowest cost.

Professor Sheldon H. Jacobson led a study that found that the pediatric vaccine market is affected by a physician’s perceptions of cost, more than actual cost.
Credit: L. Brian Stauffer

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive option, according to a new study by University of Illinois researchers.

"The choice of vaccines to administer can be driven by numerous factors," says Sheldon H. Jacobson, a co-author of the study and a professor of computer science and of mathematics at the U. of I. "In an environment where vaccines are under growing public scrutiny, no stone should be left unturned in uncovering why one combination vaccine is preferred over another. Such analyses provide information that serve to better inform and advise all stakeholders."

Only two vaccines are available now that immunize against five diseases with a single injection: Pediarix and Pentacel. Both are administered in three doses, and both immunize against polio, diphtheria, tetanus and pertussis. However, Pediarix immunizes against hepatitis B (HepB) while Pentacel immunizes against Haemophilus influenzae type B (Hib). One or the other -- but not both -- can be used as the backbone for the Recommended Childhood Immunization Schedule stipulated by the Centers for Disease Control and Prevention. Children also must receive either the HepB or Hib shot, depending on which one is missing from their combination vaccine.

"The market will gravitate toward the combination vaccine that provides the best value," said graduate student Banafsheh Behzad, the first author of the study. "From the perspective of a health care provider, the important question to ask is: Which combination vaccine should be used to attain the minimum overall cost, given a fixed cost of an injection?"

In a previous analysis, the researchers found that Pediarix is the most cost-effective combination vaccine. Yet in the public sector, Pentacel's sales have been significantly higher. The new study explores whether other factors may be influencing this market response.

The researchers found two complicating factors in HepB and Hib immunizations that can affect health care providers' decisions when comparing combination vaccines. Infants in the United States are given a dose of HepB vaccine at birth, so only two more doses are required. Therefore, children who receive three doses of Pediarix get "extra-immunized" against HepB. However, if the Merck Hib vaccine is used, one less dose is required, so children who receive Pentacel may be extra-immunized against Hib.

"Our analysis suggests that the relative uptake of the two combination vaccines Pediarix and Pentacel can be explained by health care providers either recognizing the birth dose of Hepatitis B (and hence, choosing to administer Pediarix) or ignoring the Merck Effect for Haemophilus Influenza Type B (and hence, choosing to administer Pentacel)," Behzad said.

When the costs of extra immunizations are added to the costs of the combination vaccines, Pediarix ultimately is the lower cost. The prevalence of Pentacel, however, implies that pediatricians recognize the value of the birth dose of the hepatitis B vaccine, but that they do not take into account the cost savings of administering fewer doses of the Merck Hib vaccine.

The researchers encourage physicians and advisory boards to take all factors into account when determining how to administer the best combination of vaccines for the lowest cost.

"Vaccines do not exist in an immunization vacuum," Jacobson said. "The decision to use one particular vaccine may have implications on the choice of other vaccines, even when the diseases that they cover are distinct or only partially overlapping."


Story Source:

The above story is based on materials provided by University of Illinois at Urbana-Champaign. The original article was written by Liz Ahlberg. Note: Materials may be edited for content and length.


Journal Reference:

  1. Banafsheh Behzad, MSc, Sheldon H. Jacobson, PhD, Janet A. Jokela, MD, MPH, and Edward C. Sewell, PhD. The Relationship Between Pediatric Combination Vaccines and Market Effects. American Journal of Public Health, October 2013 DOI: 10.2105/AJPH.2013.301780

Cite This Page:

University of Illinois at Urbana-Champaign. "Recalculating costs of combination vaccines." ScienceDaily. ScienceDaily, 17 April 2014. <www.sciencedaily.com/releases/2014/04/140417192008.htm>.
University of Illinois at Urbana-Champaign. (2014, April 17). Recalculating costs of combination vaccines. ScienceDaily. Retrieved August 20, 2014 from www.sciencedaily.com/releases/2014/04/140417192008.htm
University of Illinois at Urbana-Champaign. "Recalculating costs of combination vaccines." ScienceDaily. www.sciencedaily.com/releases/2014/04/140417192008.htm (accessed August 20, 2014).

Share This




More Health & Medicine News

Wednesday, August 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola-Hit Sierra Leone's Freetown a City on Edge

Ebola-Hit Sierra Leone's Freetown a City on Edge

AFP (Aug. 19, 2014) Residents of Sierra Leone's capital voice their fears as the Ebola virus sweeps through west Africa. Duration: 00:56 Video provided by AFP
Powered by NewsLook.com
101-Year-Old Working Man Has All The Advice You Need

101-Year-Old Working Man Has All The Advice You Need

Newsy (Aug. 19, 2014) Herman Goldman has worked at the same lighting store for almost 75 years. Find out his secrets to a happy, productive life. Video provided by Newsy
Powered by NewsLook.com
Researcher Testing on-Field Concussion Scanners

Researcher Testing on-Field Concussion Scanners

AP (Aug. 19, 2014) Four Texas high school football programs are trying out an experimental system designed to diagnose concussions on the field. The technology is in response to growing concern over head trauma in America's most watched sport. (Aug. 19) Video provided by AP
Powered by NewsLook.com
American Ebola Patient Apparently Improving, Outbreak Is Not

American Ebola Patient Apparently Improving, Outbreak Is Not

Newsy (Aug. 19, 2014) Nancy Writebol, an American missionary who contracted Ebola, is apparently getting better, according to her husband. The outbreak, however, is not. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins